Activating alterations in receptor tyrosine kinases and downstream effectors converge on core signaling cascades, including the RAS–RAF–MEK–ERK, PI3K–AKT–mTOR, and JAK–STAT pathways, promoting tumor cell proliferation, angiogenesis, and survival. This evidence concerns the gene MAP2K7 and neoplasm.